|
Volumn 6, Issue 2, 2001, Pages 81-84
|
The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: A substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial
|
Author keywords
ACE inhibitors; Heart failure; Systolic BP variability
|
Indexed keywords
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
LISINOPRIL;
ADULT;
ARTERIAL PRESSURE;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE REGULATION;
CIRCADIAN RHYTHM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HEART EJECTION FRACTION;
HEART FAILURE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING, AMBULATORY;
CIRCADIAN RHYTHM;
COHORT STUDIES;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
LISINOPRIL;
MALE;
MIDDLE AGED;
SURVIVAL RATE;
|
EID: 0034950178
PISSN: 13595237
EISSN: None
Source Type: Journal
DOI: 10.1097/00126097-200104000-00003 Document Type: Article |
Times cited : (7)
|
References (11)
|